An observational study in Cadmium, Placenta and Fetal Growth, sponsored by Centre Hospitalier Universitaire, Amiens. Recruiting at 1 site in France. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-02.
Sponsored by Centre Hospitalier Universitaire, Amiens · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Cadmium is a toxic heavy metal naturally present in the environment, whose human exposure has increased over recent decades due to diffuse anthropogenic contamination, particularly related to industrial activities and the use of mineral phosphate fertilizers in agriculture.
Cadmium is characterized by its bioaccumulative properties and well-established toxicity, including renal and bone damage and carcinogenic effects. In pregnant women, several animal and human cohort studies have shown that cadmium can cross the placental barrier and accumulate in placental tissue. Placental cadmium exposure has been associated with impaired placental function and adverse perinatal outcomes, including fetal growth restriction and increased neonatal morbidity. In the general population without occupational exposure, diet represents the main source of cadmium exposure, apart from tobacco smoking. Fetal growth, commonly assessed through birth weight adjusted for gestational age, is a major determinant of neonatal and long-term health outcomes. This monocentric prospective pilot study aims to assess fetal exposure to cadmium during pregnancy using placental cadmium concentration as a biomarker. Placental samples will be collected at delivery from women giving birth at Amiens University Hospital, and cadmium levels will be measured using inductively coupled plasma mass spectrometry. The association between placental cadmium concentration and fetal growth will be explored. Fetal growth will be evaluated using birth weight adjusted for gestational age, expressed as a standardized z-score. Maternal urinary and blood cadmium concentrations will also be measured to characterize maternal exposure and explore correlations between biological matrices. Placental efficiency, defined as the fetal-to-placental weight ratio, will be assessed as an indicator of placental function. The results of this pilot study will provide preliminary data to inform future larger-scale epidemiological and mechanistic studies on prenatal cadmium exposure and pregnancy outcomes.
185 studies on the registry are indexed under Birth Weight; 24 are open to participants now.
This study's planned enrollment of 50 is below the median of 240 across 63 observational studies indexed under Birth Weight.
Browse Birth Weight studies →Centre Hospitalier Universitaire, Amiens is the lead sponsor of 586 studies on the registry; 185 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Women delivering at term or preterm who are patients at Amiens University Hospital,
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
maternal blood samples are collected at admission for delivery as part of standard obstetric care.
Placental tissue samples are collected at delivery,
maternal urine samples are obtained during routine prenatal visits,
association between placental cadmium levels and fetal growth
investigate the correlation between placental cadmium levels and fetal growth.
Time frame: at 2 months
association between maternal urinary cadmium concentration and fetal growth
Correlation between maternal urinary cadmium concentration (adjusted for creatinine) and fetal growth, assessed by birth weight adjusted for gestational age (z-score).
Time frame: at 2 months
Association between maternal blood cadmium concentration and fetal growth
Association between maternal blood cadmium concentration and fetal growth, assessed by birth weight adjusted for gestational age (z-score).
Time frame: at 2 months
Association between placental cadmium concentration and placental efficiency
Association between placental cadmium concentration and placental efficiency, defined as the fetal-to-placental weight ratio
Time frame: at 2 months
Association between maternal dietary patterns and estimated dietary cadmium intake and cadmium concentrations measured in placental tissue
Association between maternal dietary patterns and estimated dietary cadmium intake and cadmium concentrations measured in placental tissue
Time frame: at 2 months
Plan to share: No
No publications or documents are linked to this record.
Started Sep 2026 (actual). Primary completion is estimated for Nov 2026, 2 months after the start.
Of 33 non-industry observational studies under Birth Weight, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 52. This study's planned 2 months is below that.
Counting every sponsor, half of 34 studies reached it within 25 months; a quarter within 10 and three quarters within 52.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Centre Hospitalier Universitaire, Amiens →